213 related articles for article (PubMed ID: 37955334)
1. Cutaneous vasculitis in autoinflammatory diseases.
Chen KR
J Dermatol; 2024 Feb; 51(2):150-159. PubMed ID: 37955334
[TBL] [Abstract][Full Text] [Related]
2. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
[TBL] [Abstract][Full Text] [Related]
3. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Pinto B; Deo P; Sharma S; Syal A; Sharma A
Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of childhood-onset polyarteritis nodosa and DADA2.
Kasap Cuceoglu M; Sener S; Batu ED; Kaya Akca U; Demir S; Sag E; Atalay E; Balık Z; Basaran O; Bilginer Y; Ozen S
Semin Arthritis Rheum; 2021 Jun; 51(3):559-564. PubMed ID: 33901990
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
Grim A; Veiga KR; Saad N
Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.
Chasset F; Francès C
Clin Rev Allergy Immunol; 2017 Dec; 53(3):452-468. PubMed ID: 28547523
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis in Systemic Autoinflammatory Diseases.
Demir S; Sag E; Dedeoglu F; Ozen S
Front Pediatr; 2018; 6():377. PubMed ID: 30560109
[TBL] [Abstract][Full Text] [Related]
10. Monogenic polyarteritis: the lesson of ADA2 deficiency.
Caorsi R; Penco F; Schena F; Gattorno M
Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
[TBL] [Abstract][Full Text] [Related]
11. Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2).
Clarke K; Campbell C; Omoyinmi E; Hong Y; Al Obaidi M; Sebire N; Brogan PA
Pediatr Rheumatol Online J; 2019 Jul; 17(1):39. PubMed ID: 31291964
[TBL] [Abstract][Full Text] [Related]
12. A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran.
Asna Ashari K; Aslani N; Parvaneh N; Assari R; Heidari M; Fathi M; Tahghighi Sharabian F; Ronagh A; Shahrooei M; Moafi A; Rezaei N; Ziaee V
Pediatr Rheumatol Online J; 2023 Jun; 21(1):55. PubMed ID: 37312195
[TBL] [Abstract][Full Text] [Related]
13. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
Sahin S; Adrovic A; Barut K; Ugurlu S; Turanli ET; Ozdogan H; Kasapcopur O
Rheumatol Int; 2018 Jan; 38(1):129-136. PubMed ID: 28516235
[TBL] [Abstract][Full Text] [Related]
14. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
15. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
[TBL] [Abstract][Full Text] [Related]
16. A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants.
Parlar K; Tahir Turanli E; Nuhoglu Kantarci E; Hacioglu A; Kirectepe Aydin A; Ayla AY; Voyvoda U; Ozdogan H; Ugurlu S
Mod Rheumatol Case Rep; 2023 Dec; 8(1):121-124. PubMed ID: 37542433
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.
Pilania RK; Banday AZ; Sharma S; Kumrah R; Joshi V; Loganathan S; Dhaliwal M; Jindal AK; Vignesh P; Suri D; Rawat A; Singh S
Front Immunol; 2022; 13():869570. PubMed ID: 35592317
[TBL] [Abstract][Full Text] [Related]
18. VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.
Loeza-Uribe MP; Hinojosa-Azaola A; Sánchez-Hernández BE; Crispín JC; Apodaca-Chávez E; Ferrada MA; Martín-Nares E
Reumatol Clin (Engl Ed); 2024 Jan; 20(1):47-56. PubMed ID: 38160120
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous alterations in vasculitides : Part 2: Special aspects of diseases of large, medium and small vessels].
Sunderkötter C; Michl C
Internist (Berl); 2019 Aug; 60(8):805-813. PubMed ID: 31300830
[TBL] [Abstract][Full Text] [Related]
20. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist.
Sterling D; Duncan ME; Philippidou M; Salisbury JR; Kulasekararaj AG; Basu TN
J Am Acad Dermatol; 2023 Dec; 89(6):1209-1214. PubMed ID: 35121074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
